Company page

Harrow, Inc.

Harrow, Inc. is a publicly traded company in the American market, identified by the ticker HROW. The company has a market capitalization of approximately $1.6 billion. Harrow focuses on developing and commercializing innovative ophthalmic pharmaceuticals.

profileHROW:NASDAQAI content: aiUpdated June 24, 2026/company/harrow-health-inc/c-u9wp0bmu
Harrow, Inc. logo
Ticker
HROW:NASDAQ
Asset type
Stock
Market cap
$1.60B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
NASDAQ
Currency
USD